Literature DB >> 36206307

Immunization with inactivated whole virus particle influenza virus vaccines improves the humoral response landscape in cynomolgus macaques.

Brendon Y Chua1,2, Toshiki Sekiya1,2,3, Marios Koutsakos2, Naoki Nomura3, Louise C Rowntree2, Thi H O Nguyen2, Hayley A McQuilten2, Marumi Ohno3, Yuki Ohara4, Tomohiro Nishimura4, Masafumi Endo4, Yasushi Itoh5, Jennifer R Habel2, Kevin J Selva2, Adam K Wheatley2, Bruce D Wines6,7,8, P Mark Hogarth6,7,8, Stephen J Kent2,9, Amy W Chung2, David C Jackson1,2, Lorena E Brown1,2, Masashi Shingai1,3, Katherine Kedzierska1,2, Hiroshi Kida1,3.   

Abstract

Although antibody-inducing split virus vaccines (SV) are currently the most effective way to combat seasonal influenza, their efficacy can be modest, especially in immunologically-naïve individuals. We investigated immune responses towards inactivated whole influenza virus particle vaccine (WPV) formulations, predicated to be more immunogenic, in a non-human primate model, as an important step towards clinical testing in humans. Comprehensive analyses were used to capture 46 immune parameters to profile how WPV-induced responses differed to those elicited by antigenically-similar SV formulations. Naïve cynomolgus macaques vaccinated with either monovalent or quadrivalent WPV consistently induced stronger antibody responses and hemagglutination inhibition (HI) antibody titres against vaccine-matched viruses compared to SV formulations, while acute reactogenic effects were similar. Responses in WPV-primed animals were further increased by boosting with the same formulation, conversely to modest responses after priming and boosting with SV. 28-parameter multiplex bead array defined key antibody features and showed that while both WPV and SV induced elevated IgG responses against A/H1N1 nucleoprotein, only WPV increased IgG responses against A/H1N1 hemagglutinin (HA) and HA-Stem, and higher IgA responses to A/H1N1-HA after each vaccine dose. Antibodies to A/H1N1-HA and HA-Stem that could engage FcγR2a and FcγR3a were also present at higher levels after one dose of WPV compared to SV and remained elevated after the second dose. Furthermore, WPV-enhanced antibody responses were associated with higher frequencies of HA-specific B-cells and IFN-γ-producing CD4+ T-cell responses. Our data additionally demonstrate stronger boosting of HI titres by WPV following prior infection and support WPV administered as a priming dose irrespective of the follow up vaccine for the second dose. Our findings thus show that compared to SV vaccination, WPV-induced humoral responses are significantly increased in scope and magnitude, advocating WPV vaccination regimens for priming immunologically-naïve individuals and also in the event of a pandemic outbreak.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 36206307      PMCID: PMC9581423          DOI: 10.1371/journal.ppat.1010891

Source DB:  PubMed          Journal:  PLoS Pathog        ISSN: 1553-7366            Impact factor:   7.464


  45 in total

1.  Comparison of adverse reactions to whole-virion and split-virion influenza vaccines in hospital personnel.

Authors:  A al-Mazrou; D W Scheifele; T Soong; G Bjornson
Journal:  CMAJ       Date:  1991-08-01       Impact factor: 8.262

Review 2.  An update on influenza vaccination in patients with egg allergy.

Authors:  David A Gruenberg; Marcus S Shaker
Journal:  Curr Opin Pediatr       Date:  2011-10       Impact factor: 2.856

3.  Safety and immunogenicity of influenza whole inactivated virus vaccines: A phase I randomized clinical trial.

Authors:  Renée A J van Boxtel; Pauline Verdijk; Otto J de Boer; Elly van Riet; Tjeert T Mensinga; Willem Luytjes
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

4.  Whole-Virion Influenza Vaccine Recalls an Early Burst of High-Affinity Memory B Cell Response through TLR Signaling.

Authors:  Taishi Onodera; Akira Hosono; Takato Odagiri; Masato Tashiro; Shuichi Kaminogawa; Yoshinobu Okuno; Tomohiro Kurosaki; Manabu Ato; Kazuo Kobayashi; Yoshimasa Takahashi
Journal:  J Immunol       Date:  2016-04-06       Impact factor: 5.422

5.  H5N1 Vaccine-Elicited Memory B Cells Are Genetically Constrained by the IGHV Locus in the Recognition of a Neutralizing Epitope in the Hemagglutinin Stem.

Authors:  Adam K Wheatley; James R R Whittle; Daniel Lingwood; Masaru Kanekiyo; Hadi M Yassine; Steven S Ma; Sandeep R Narpala; Madhu S Prabhakaran; Rodrigo A Matus-Nicodemos; Robert T Bailer; Gary J Nabel; Barney S Graham; Julie E Ledgerwood; Richard A Koup; Adrian B McDermott
Journal:  J Immunol       Date:  2015-06-15       Impact factor: 5.422

6.  Immune profiling of influenza-specific B- and T-cell responses in macaques using flow cytometry-based assays.

Authors:  Marios Koutsakos; Toshiki Sekiya; Brendon Y Chua; Thi Hoang Oanh Nguyen; Adam K Wheatley; Jennifer A Juno; Marumi Ohno; Naoki Nomura; Yuki Ohara; Tomohiro Nishimura; Masafumi Endo; Saori Suzuki; Hirohito Ishigaki; Misako Nakayama; Cong T Nguyen; Yasushi Itoh; Masashi Shingai; Kazumasa Ogasawara; Yoichiro Kino; Stephen J Kent; David C Jackson; Lorena E Brown; Hiroshi Kida; Katherine Kedzierska
Journal:  Immunol Cell Biol       Date:  2020-09-07       Impact factor: 5.126

7.  Which influenza viruses will emerge following the SARS-CoV-2 pandemic?

Authors:  Karen L Laurie; Steve Rockman
Journal:  Influenza Other Respir Viruses       Date:  2021-05-06       Impact factor: 5.606

8.  Critical role of TLR7 signaling in the priming of cross-protective cytotoxic T lymphocyte responses by a whole inactivated influenza virus vaccine.

Authors:  Natalija Budimir; Aalzen de Haan; Tjarko Meijerhof; Simke Waijer; Louis Boon; Emma Gostick; David A Price; Jan Wilschut; Anke Huckriede
Journal:  PLoS One       Date:  2013-05-02       Impact factor: 3.240

9.  Innate responses induced by whole inactivated virus or subunit influenza vaccines in cultured dendritic cells correlate with immune responses in vivo.

Authors:  Maaike Stoel; Judith Pool; Jacqueline de Vries-Idema; Fatiha Zaaraoui-Boutahar; Maarten Bijl; Arno C Andeweg; Jan Wilschut; Anke Huckriede
Journal:  PLoS One       Date:  2015-05-01       Impact factor: 3.240

10.  Glycan repositioning of influenza hemagglutinin stem facilitates the elicitation of protective cross-group antibody responses.

Authors:  Seyhan Boyoglu-Barnum; Geoffrey B Hutchinson; Jeffrey C Boyington; Syed M Moin; Rebecca A Gillespie; Yaroslav Tsybovsky; Tyler Stephens; John R Vaile; Julia Lederhofer; Kizzmekia S Corbett; Brian E Fisher; Hadi M Yassine; Sarah F Andrews; Michelle C Crank; Adrian B McDermott; John R Mascola; Barney S Graham; Masaru Kanekiyo
Journal:  Nat Commun       Date:  2020-02-07       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.